| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.712 | 0.005 | 0.752 | Spasmolytic | 0.752 0.005 DBMET02499 0.739 0.005 DBMET02500 | DBMET02499 | |
| 0.602 | 0.019 | 0.686 | Aldehyde oxidase inhibitor | 0.65 0.013 DBMET02499 0.686 0.009 DBMET02500 | DBMET02500 | |
| 0.58 | 0.021 | 0.632 | Cholesterol antagonist | 0.632 0.015 DBMET02499 0.566 0.023 DBMET02500 | DBMET02499 | |
| 0.564 | 0.01 | 0.565 | Cardiotonic | 0.565 0.01 DBMET02499 0.506 0.015 DBMET02500 | DBMET02499 | |
| 0.555 | 0.01 | 0.556 | Vasodilator, coronary | 0.533 0.012 DBMET02499 0.556 0.01 DBMET02500 | DBMET02500 | |
| 0.522 | 0.007 | 0.522 | P-glycoprotein inhibitor | 0.494 0.009 DBMET02499 0.509 0.008 DBMET02500 | ||
| 0.524 | 0.022 | 0.591 | Histamine release inhibitor | 0.591 0.011 DBMET02499 0.543 0.017 DBMET02500 | DBMET02499 | |
| 0.495 | 0.034 | 0.496 | 5 Hydroxytryptamine release inhibitor | 0.467 0.044 DBMET02499 0.496 0.034 DBMET02500 | DBMET02500 | |
| 0.468 | 0.034 | 0.515 | Antithrombotic | 0.515 0.027 DBMET02499 0.469 0.034 DBMET02500 | DBMET02499 | |
| 0.466 | 0.036 | 0.466 | Vasodilator, peripheral | 0.465 0.036 DBMET02499 0.455 0.039 DBMET02500 | ||
| 0.424 | 0.005 | 0.445 | Anesthetic local | 0.445 0.005 DBMET02499 0.395 0.007 DBMET02500 | DBMET02499 | |
| 0.425 | 0.019 | 0.47 | Vasodilator | 0.47 0.014 DBMET02499 0.436 0.018 DBMET02500 | DBMET02499 | |
| 0.443 | 0.037 | 0.443 | 5 Hydroxytryptamine release stimulant | 0.383 0.049 DBMET02499 0.386 0.049 DBMET02500 | ||
| 0.415 | 0.017 | 0.415 | Platelet aggregation inhibitor | 0.307 0.034 DBMET02499 0.338 0.028 DBMET02500 | ||
| 0.367 | 0.021 | 0.378 | Anesthetic general | 0.378 0.019 DBMET02499 0.32 0.029 DBMET02500 | DBMET02499 | |
| 0.348 | 0.004 | 0.348 | Calcium antagonist | 0.24 0.009 DBMET02499 0.248 0.008 DBMET02500 | ||
| 0.362 | 0.028 | 0.375 | DNA synthesis inhibitor | 0.375 0.025 DBMET02499 0.362 0.028 DBMET02500 | DBMET02499 | |
| 0.356 | 0.031 | 0.38 | Transcription factor STAT3 inhibitor | 0.38 0.023 DBMET02499 0.373 0.025 DBMET02500 | DBMET02499 | |
| 0.359 | 0.038 | 0.384 | DNA damaging | 0.373 0.035 DBMET02499 0.384 0.032 DBMET02500 | DBMET02500 | |
| 0.384 | 0.07 | 0.401 | Immunosuppressant | 0.401 0.062 DBMET02499 0.38 0.072 DBMET02500 | DBMET02499 | |
| 0.32 | 0.016 | 0.427 | Amylase inhibitor | 0.381 0.01 DBMET02499 0.427 0.008 DBMET02500 | DBMET02500 | |
| 0.331 | 0.032 | 0.492 | Peroxidase inhibitor | 0.492 0.01 DBMET02499 0.466 0.013 DBMET02500 | DBMET02499 | |
| 0.298 | 0.012 | 0.347 | Aldehyde dehydrogenase inhibitor | 0.337 0.009 DBMET02499 0.347 0.008 DBMET02500 | DBMET02500 | |
| 0.285 | 0.009 | 0.304 | Expectorant | 0.288 0.009 DBMET02499 0.304 0.008 DBMET02500 | DBMET02500 | |
| 0.3 | 0.026 | 0.328 | DNA methyltransferase I inhibitor | 0.3 0.026 DBMET02499 0.328 0.018 DBMET02500 | DBMET02500 | |
| 0.314 | 0.048 | 0.359 | Transcription factor STAT inhibitor | 0.359 0.031 DBMET02499 0.343 0.037 DBMET02500 | DBMET02499 | |
| 0.295 | 0.032 | 0.371 | RNA-directed DNA polymerase inhibitor | 0.371 0.021 DBMET02499 0.347 0.024 DBMET02500 | DBMET02499 | |
| 0.303 | 0.042 | 0.303 | Psychostimulant | 0.301 0.042 DBMET02499 0.291 0.045 DBMET02500 | ||
| 0.272 | 0.01 | 0.272 | Nav1.1 sodium channel blocker | 0.271 0.01 DBMET02499 0.242 0.013 DBMET02500 | ||
| 0.302 | 0.041 | 0.318 | Cyclic AMP phosphodiesterase inhibitor | 0.308 0.039 DBMET02499 0.318 0.035 DBMET02500 | DBMET02500 | |
| 0.265 | 0.01 | 0.273 | ATPase inhibitor | 0.273 0.009 DBMET02499 0.263 0.011 DBMET02500 | DBMET02499 | |
| 0.259 | 0.005 | 0.274 | Mucolytic | 0.262 0.005 DBMET02499 0.274 0.005 DBMET02500 | DBMET02500 | |
| 0.286 | 0.032 | 0.313 | DNA methylase inhibitor | 0.288 0.031 DBMET02499 0.313 0.024 DBMET02500 | DBMET02500 | |
| 0.268 | 0.015 | 0.306 | Alkylator | 0.276 0.014 DBMET02499 0.306 0.012 DBMET02500 | DBMET02500 | |
| 0.316 | 0.065 | 0.333 | Sodium/bile acid cotransporter inhibitor | 0.33 0.054 DBMET02499 0.333 0.052 DBMET02500 | DBMET02500 | |
| 0.355 | 0.113 | 0.38 | Calcium channel L-type activator | 0.355 0.113 DBMET02499 0.38 0.095 DBMET02500 | DBMET02500 | |
| 0.293 | 0.053 | 0.351 | Superoxide dismutase inhibitor | 0.326 0.042 DBMET02499 0.351 0.036 DBMET02500 | DBMET02500 | |
| 0.286 | 0.048 | 0.294 | Antimitotic | 0.239 0.064 DBMET02499 0.294 0.045 DBMET02500 | DBMET02500 | |
| 0.245 | 0.01 | 0.245 | Microtubule formation inhibitor | 0.242 0.011 DBMET02499 0.239 0.011 DBMET02500 | ||
| 0.234 | 0.005 | 0.234 | Sphingomyelinase inhibitor | 0.189 0.012 DBMET02499 0.197 0.01 DBMET02500 | ||
| 0.248 | 0.02 | 0.286 | Insulin secretagoues | 0.286 0.014 DBMET02499 0.229 0.024 DBMET02500 | DBMET02499 | |
| 0.308 | 0.084 | 0.308 | Calcium channel activator | 0.234 0.167 DBMET02499 0.281 0.112 DBMET02500 | ||
| 0.273 | 0.048 | 0.273 | Anticonvulsant | 0.259 0.054 DBMET02499 0.155 0.123 DBMET02500 | ||
| 0.247 | 0.023 | 0.266 | Succinate dehydrogenase inhibitor | 0.266 0.018 DBMET02499 0.222 0.034 DBMET02500 | DBMET02499 | |
| 0.242 | 0.018 | 0.242 | Antiadrenergic | 0.234 0.019 DBMET02499 0.199 0.024 DBMET02500 | ||
| 0.243 | 0.023 | 0.243 | Nav1.2 sodium channel blocker | 0.204 0.033 DBMET02499 0.183 0.041 DBMET02500 | ||
| 0.237 | 0.018 | 0.237 | Adrenaline antagonist | 0.229 0.019 DBMET02499 0.195 0.024 DBMET02500 | ||
| 0.233 | 0.017 | 0.233 | Nav1.3 sodium channel blocker | 0.185 0.03 DBMET02499 0.172 0.036 DBMET02500 | ||
| 0.249 | 0.035 | 0.267 | Insulin sensitizer | 0.267 0.026 DBMET02499 0.249 0.035 DBMET02500 | DBMET02499 | |
| 0.269 | 0.066 | 0.326 | Hypoglycemic | 0.326 0.044 DBMET02499 0.326 0.044 DBMET02500 | DBMET02500 | |
| 0.211 | 0.01 | 0.274 | Triose-phosphate isomerase inhibitor | 0.274 0.005 DBMET02499 0.153 0.019 DBMET02500 | DBMET02499 | |
| 0.283 | 0.084 | 0.348 | Immunostimulant | 0.348 0.065 DBMET02499 0.323 0.072 DBMET02500 | DBMET02499 | |
| 0.214 | 0.018 | 0.236 | Toll-Like receptor 2 antagonist | 0.236 0.012 DBMET02499 0.226 0.014 DBMET02500 | DBMET02499 | |
| 0.237 | 0.042 | 0.27 | Nitric-oxide synthase stimulant | 0.259 0.027 DBMET02499 0.27 0.021 DBMET02500 | DBMET02500 | |
| 0.207 | 0.027 | 0.26 | Cell wall synthesis inhibitor | 0.26 0.014 DBMET02499 0.224 0.022 DBMET02500 | DBMET02499 | |
| 0.308 | 0.129 | 0.396 | Antibacterial | 0.396 0.079 DBMET02499 0.369 0.091 DBMET02500 | DBMET02499 | |
| 0.336 | 0.158 | 0.406 | Caspase 9 stimulant | 0.33 0.163 DBMET02499 0.406 0.107 DBMET02500 | DBMET02500 | |
| 0.184 | 0.01 | 0.257 | Keratolytic | 0.232 0.006 DBMET02499 0.257 0.005 DBMET02500 | DBMET02500 | |
| 0.203 | 0.03 | 0.216 | Catenin beta inhibitor | 0.201 0.031 DBMET02499 0.216 0.022 DBMET02500 | DBMET02500 | |
| 0.189 | 0.017 | 0.189 | Catalase inhibitor | 0.174 0.02 DBMET02499 0.15 0.026 DBMET02500 | ||
| 0.187 | 0.021 | 0.228 | Adenylate cyclase stimulant | 0.228 0.005 DBMET02499 0.191 0.018 DBMET02500 | DBMET02499 | |
| 0.17 | 0.006 | 0.17 | Glutamate release inhibitor | 0.137 0.014 DBMET02499 0.135 0.014 DBMET02500 | ||
| 0.184 | 0.027 | 0.19 | Antibacterial (Helicobacter pylori) | 0.19 0.025 DBMET02499 0.185 0.026 DBMET02500 | DBMET02499 | |
| 0.199 | 0.043 | 0.221 | Phospholipase A2 inhibitor | 0.221 0.033 DBMET02499 0.203 0.041 DBMET02500 | DBMET02499 | |
| 0.179 | 0.025 | 0.2 | Antineoplastic antibiotic | 0.2 0.021 DBMET02499 0.196 0.022 DBMET02500 | DBMET02499 | |
| 0.181 | 0.028 | 0.181 | Nav1.6 sodium channel blocker | 0.161 0.042 DBMET02499 0.159 0.045 DBMET02500 | ||
| 0.189 | 0.037 | 0.261 | Alpha-N-acetylglucosaminidase inhibitor | 0.261 0.021 DBMET02499 0.157 0.051 DBMET02500 | DBMET02499 | |
| 0.182 | 0.031 | 0.182 | Platelet activating factor antagonist | 0.093 0.085 DBMET02499 0.141 0.05 DBMET02500 | ||
| 0.16 | 0.01 | 0.204 | Carbamoyl phosphate synthetase inhibitor | 0.204 0.007 DBMET02499 0.135 0.013 DBMET02500 | DBMET02499 | |
| 0.151 | 0.006 | 0.18 | Beta adrenoreceptor antagonist | 0.18 0.004 DBMET02499 0.172 0.005 DBMET02500 | DBMET02499 | |
| 0.148 | 0.005 | 0.167 | Beta 1 adrenoreceptor antagonist | 0.167 0.004 DBMET02499 0.155 0.005 DBMET02500 | DBMET02499 | |
| 0.173 | 0.033 | 0.24 | Interleukin 4 antagonist | 0.238 0.015 DBMET02499 0.24 0.014 DBMET02500 | DBMET02500 | |
| 0.154 | 0.018 | 0.154 | Acetylcholine M3 receptor agonist | 0.146 0.022 DBMET02499 0.128 0.03 DBMET02500 | ||
| 0.169 | 0.034 | 0.178 | Cyclooxygenase 3 inhibitor | 0.174 0.031 DBMET02499 0.178 0.028 DBMET02500 | DBMET02500 | |
| 0.304 | 0.169 | 0.409 | Apoptosis agonist | 0.366 0.13 DBMET02499 0.409 0.109 DBMET02500 | DBMET02500 | |
| 0.211 | 0.078 | 0.211 | ErbB-1 antagonist | 0.179 0.117 DBMET02499 0.204 0.085 DBMET02500 | ||
| 0.142 | 0.011 | 0.209 | Alcohol oxidase inhibitor | 0.209 0.006 DBMET02499 0.178 0.008 DBMET02500 | DBMET02499 | |
| 0.183 | 0.053 | 0.206 | Interleukin 6 antagonist | 0.206 0.037 DBMET02499 0.195 0.044 DBMET02500 | DBMET02499 | |
| 0.2 | 0.071 | 0.2 | Non-steroidal antiinflammatory agent | 0.192 0.078 DBMET02499 0.185 0.083 DBMET02500 | ||
| 0.147 | 0.018 | 0.156 | MAP kinase kinase 1 inhibitor | 0.156 0.014 DBMET02499 0.129 0.027 DBMET02500 | DBMET02499 | |
| 0.18 | 0.061 | 0.237 | Phospholipase C inhibitor | 0.237 0.028 DBMET02499 0.183 0.057 DBMET02500 | DBMET02499 | |
| 0.221 | 0.103 | 0.279 | Tyrosine 3 hydroxylase inhibitor | 0.279 0.045 DBMET02499 0.237 0.081 DBMET02500 | DBMET02499 | |
| 0.226 | 0.11 | 0.226 | Gastrin inhibitor | 0.205 0.141 DBMET02499 | ||
| 0.207 | 0.091 | 0.254 | Peptidyltransferase inhibitor | 0.254 0.048 DBMET02499 0.216 0.08 DBMET02500 | DBMET02499 | |
| 0.142 | 0.026 | 0.15 | Toll-Like receptor 4 antagonist | 0.144 0.024 DBMET02499 0.15 0.021 DBMET02500 | DBMET02500 | |
| 0.173 | 0.058 | 0.218 | Diuretic | 0.218 0.038 DBMET02499 0.153 0.075 DBMET02500 | DBMET02499 | |
| 0.209 | 0.094 | 0.284 | Antiamyloidogenic | 0.236 0.077 DBMET02499 0.284 0.057 DBMET02500 | DBMET02500 | |
| 0.127 | 0.015 | 0.129 | ATPase (Vacuolar H+) inhibitor | 0.129 0.015 DBMET02499 0.122 0.018 DBMET02500 | DBMET02499 | |
| 0.139 | 0.032 | 0.139 | Gastric antisecretory | 0.122 0.041 DBMET02499 0.114 0.049 DBMET02500 | ||
| 0.147 | 0.041 | 0.152 | Vanilloid 1 agonist | 0.152 0.036 DBMET02499 0.152 0.036 DBMET02500 | DBMET02500 | |
| 0.131 | 0.027 | 0.195 | Topoisomerase II alpha inhibitor | 0.174 0.019 DBMET02499 0.195 0.015 DBMET02500 | DBMET02500 | |
| 0.126 | 0.023 | 0.187 | Adrenaline agonist | 0.187 0.008 DBMET02499 0.154 0.014 DBMET02500 | DBMET02499 | |
| 0.164 | 0.061 | 0.261 | Heat shock protein 90 antagonist | 0.194 0.041 DBMET02499 0.261 0.018 DBMET02500 | DBMET02500 | |
| 0.108 | 0.005 | 0.108 | Calcium channel P-type blocker | 0.069 0.03 DBMET02499 0.075 0.02 DBMET02500 | ||
| 0.219 | 0.118 | 0.255 | 5 Hydroxytryptamine uptake stimulant | 0.255 0.076 DBMET02499 0.193 0.166 DBMET02500 | DBMET02499 | |
| 0.225 | 0.124 | 0.278 | Hypoxia-inducible factor 1 alpha inhibitor | 0.245 0.105 DBMET02499 0.278 0.077 DBMET02500 | DBMET02500 | |
| 0.195 | 0.098 | 0.216 | Hypolipemic | 0.216 0.084 DBMET02499 0.193 0.099 DBMET02500 | DBMET02499 | |
| 0.109 | 0.012 | 0.132 | Beta 3 adrenoreceptor antagonist | 0.132 0.008 DBMET02499 0.117 0.01 DBMET02500 | DBMET02499 | |
| 0.162 | 0.067 | 0.217 | Melanin inhibitor | 0.176 0.054 DBMET02499 0.217 0.035 DBMET02500 | DBMET02500 | |
| 0.113 | 0.021 | 0.147 | Histone deacetylase SIRT1 stimulant | 0.139 0.011 DBMET02499 0.147 0.01 DBMET02500 | DBMET02500 | |
| 0.113 | 0.021 | 0.147 | Histone deacetylase stimulant | 0.139 0.011 DBMET02499 0.147 0.01 DBMET02500 | DBMET02500 | |
| 0.099 | 0.009 | 0.099 | Exportin-1 inhibitor | 0.085 0.019 DBMET02499 0.079 0.027 DBMET02500 | ||
| 0.129 | 0.04 | 0.155 | Mediator release inhibitor | 0.155 0.026 DBMET02499 0.149 0.029 DBMET02500 | DBMET02499 | |
| 0.148 | 0.061 | 0.195 | MAO inhibitor | 0.181 0.047 DBMET02499 0.195 0.042 DBMET02500 | DBMET02500 | |
| 0.172 | 0.087 | 0.21 | Hepatoprotectant | 0.202 0.064 DBMET02499 0.21 0.059 DBMET02500 | DBMET02500 | |
| 0.107 | 0.023 | 0.284 | Phenylalanine 4-hydroxylase inhibitor | 0.284 0.004 DBMET02499 0.113 0.02 DBMET02500 | DBMET02499 | |
| 0.125 | 0.042 | 0.138 | Bronchodilator | 0.112 0.051 DBMET02499 0.138 0.036 DBMET02500 | DBMET02500 | |
| 0.138 | 0.056 | 0.138 | Cathepsin H inhibitor | 0.128 0.065 DBMET02499 0.104 0.1 DBMET02500 | ||
| 0.138 | 0.056 | 0.2 | DNA polymerase I inhibitor | 0.2 0.028 DBMET02499 0.176 0.037 DBMET02500 | DBMET02499 | |
| 0.134 | 0.053 | 0.239 | Monophenol monooxygenase inhibitor | 0.199 0.034 DBMET02499 0.239 0.025 DBMET02500 | DBMET02500 | |
| 0.127 | 0.046 | 0.145 | Nav1.4 sodium channel blocker | 0.145 0.036 DBMET02499 0.132 0.043 DBMET02500 | DBMET02499 | |
| 0.125 | 0.044 | 0.125 | Protease inhibitor | 0.123 0.045 DBMET02499 0.115 0.052 DBMET02500 | ||
| 0.087 | 0.007 | 0.087 | Lysophosphatidic acid 3 receptor antagonist | 0.078 0.01 DBMET02499 0.073 0.013 DBMET02500 | ||
| 0.091 | 0.014 | 0.144 | Heat shock protein 90 beta antagonist | 0.122 0.006 DBMET02499 0.144 0.005 DBMET02500 | DBMET02500 | |
| 0.119 | 0.044 | 0.143 | Adenylate kinase inhibitor | 0.143 0.029 DBMET02499 0.1 0.067 DBMET02500 | DBMET02499 | |
| 0.145 | 0.071 | 0.188 | Protein kinase stimulant | 0.165 0.058 DBMET02499 0.188 0.046 DBMET02500 | DBMET02500 | |
| 0.083 | 0.011 | 0.12 | Beta 2 adrenoreceptor antagonist | 0.12 0.006 DBMET02499 0.103 0.008 DBMET02500 | DBMET02499 | |
| 0.115 | 0.044 | 0.115 | Factor V inhibitor | 0.114 0.045 DBMET02499 0.104 0.061 DBMET02500 | ||
| 0.093 | 0.022 | 0.105 | GABA B receptor agonist | 0.105 0.013 DBMET02499 0.101 0.016 DBMET02500 | DBMET02499 | |
| 0.194 | 0.126 | 0.24 | Interleukin agonist | 0.24 0.086 DBMET02499 0.179 0.14 DBMET02500 | DBMET02499 | |
| 0.182 | 0.115 | 0.194 | Platelet antagonist | 0.194 0.105 DBMET02499 0.161 0.134 DBMET02500 | DBMET02499 | |
| 0.114 | 0.047 | 0.174 | UDP-glucose 4-epimerase inhibitor | 0.174 0.022 DBMET02499 0.104 0.057 DBMET02500 | DBMET02499 | |
| 0.114 | 0.048 | 0.168 | Carbonic anhydrase III inhibitor | 0.168 0.023 DBMET02499 0.165 0.024 DBMET02500 | DBMET02499 | |
| 0.189 | 0.124 | 0.324 | Antioxidant | 0.324 0.054 DBMET02499 0.324 0.054 DBMET02500 | DBMET02500 | |
| 0.186 | 0.121 | 0.202 | Tumour necrosis factor alpha release inhibitor | 0.202 0.108 DBMET02500 | DBMET02500 | |
| 0.104 | 0.039 | 0.123 | NADH dehydrogenase inhibitor | 0.123 0.027 DBMET02499 0.101 0.043 DBMET02500 | DBMET02499 | |
| 0.097 | 0.033 | 0.18 | Histidine decarboxylase inhibitor | 0.166 0.017 DBMET02499 0.18 0.015 DBMET02500 | DBMET02500 | |
| 0.133 | 0.069 | 0.162 | Tubulin antagonist | 0.103 0.098 DBMET02499 0.162 0.053 DBMET02500 | DBMET02500 | |
| 0.099 | 0.037 | 0.099 | Granulocyte macrophage colony stimulating factor agonist | 0.093 0.046 DBMET02499 0.087 0.058 DBMET02500 | ||
| 0.162 | 0.1 | 0.282 | Amyloid beta aggregation inhibitor | 0.273 0.051 DBMET02499 0.282 0.049 DBMET02500 | DBMET02500 | |
| 0.103 | 0.041 | 0.118 | Ornithine decarboxylase inhibitor | 0.118 0.027 DBMET02499 0.104 0.04 DBMET02500 | DBMET02499 | |
| 0.17 | 0.108 | 0.209 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.191 0.08 DBMET02499 0.209 0.065 DBMET02500 | DBMET02500 | |
| 0.089 | 0.027 | 0.089 | Acetylcholine M5 receptor agonist | |||
| 0.114 | 0.053 | 0.148 | MAO B inhibitor | 0.138 0.042 DBMET02499 0.148 0.038 DBMET02500 | DBMET02500 | |
| 0.065 | 0.005 | 0.065 | Calcium-sensing receptor antagonist | 0.064 0.005 DBMET02499 0.044 0.005 DBMET02500 | ||
| 0.124 | 0.064 | 0.124 | DNA repair enzyme inhibitor | 0.123 0.066 DBMET02499 0.116 0.081 DBMET02500 | ||
| 0.111 | 0.051 | 0.111 | Platelet activating factor alpha antagonist | 0.097 0.062 DBMET02500 | ||
| 0.094 | 0.034 | 0.146 | Phosphofructokinase-1 inhibitor | 0.146 0.019 DBMET02499 0.087 0.037 DBMET02500 | DBMET02499 | |
| 0.091 | 0.035 | 0.159 | Glutamate decarboxylase inhibitor | 0.159 0.011 DBMET02499 0.119 0.021 DBMET02500 | DBMET02499 | |
| 0.145 | 0.094 | 0.171 | Arachidonic acid antagonist | 0.171 0.064 DBMET02499 0.129 0.113 DBMET02500 | DBMET02499 | |
| 0.07 | 0.018 | 0.072 | Aconitate hydratase inhibitor | 0.072 0.017 DBMET02499 0.046 0.045 DBMET02500 | DBMET02499 | |
| 0.06 | 0.012 | 0.068 | Sphingosine 1-phosphate receptor 3 agonist | 0.068 0.01 DBMET02499 0.05 0.016 DBMET02500 | DBMET02499 | |
| 0.152 | 0.104 | 0.18 | Platelet adhesion inhibitor | 0.18 0.082 DBMET02499 0.174 0.086 DBMET02500 | DBMET02499 | |
| 0.171 | 0.123 | 0.329 | Free radical scavenger | 0.329 0.044 DBMET02499 0.329 0.044 DBMET02500 | DBMET02500 | |
| 0.068 | 0.021 | 0.068 | Acetylcholine M2 receptor agonist | 0.063 0.025 DBMET02499 0.057 0.032 DBMET02500 | ||
| 0.085 | 0.04 | 0.102 | GABA aminotransferase inhibitor | 0.102 0.025 DBMET02499 0.084 0.041 DBMET02500 | DBMET02499 | |
| 0.111 | 0.067 | 0.111 | Nav1.5 sodium channel blocker | 0.104 0.077 DBMET02499 0.097 0.09 DBMET02500 | ||
| 0.065 | 0.022 | 0.067 | Epithelial sodium channel blocker | 0.067 0.021 DBMET02499 0.059 0.03 DBMET02500 | DBMET02499 | |
| 0.074 | 0.032 | 0.076 | Protease 3C (Human rhinovirus) inhibitor | 0.076 0.03 DBMET02499 0.069 0.038 DBMET02500 | DBMET02499 | |
| 0.138 | 0.096 | 0.153 | Interferon gamma antagonist | 0.152 0.075 DBMET02499 0.153 0.074 DBMET02500 | DBMET02500 | |
| 0.205 | 0.164 | 0.288 | Transcription factor NF kappa B inhibitor | 0.255 0.124 DBMET02499 0.288 0.101 DBMET02500 | DBMET02500 | |
| 0.064 | 0.023 | 0.064 | Alpha-mannosidase inhibitor | 0.064 0.022 DBMET02499 0.058 0.03 DBMET02500 | ||
| 0.112 | 0.073 | 0.127 | Cholesterol synthesis inhibitor | 0.127 0.059 DBMET02499 0.126 0.06 DBMET02500 | DBMET02499 | |
| 0.117 | 0.079 | 0.117 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.056 | 0.019 | 0.06 | Mannosidase inhibitor | 0.06 0.017 DBMET02499 0.048 0.027 DBMET02500 | DBMET02499 | |
| 0.065 | 0.028 | 0.082 | Ornithine carbamoyltransferase inhibitor | 0.082 0.021 DBMET02499 0.049 0.04 DBMET02500 | DBMET02499 | |
| 0.111 | 0.076 | 0.169 | Topoisomerase II inhibitor | 0.147 0.051 DBMET02499 0.169 0.042 DBMET02500 | DBMET02500 | |
| 0.05 | 0.017 | 0.068 | Beta adrenoreceptor agonist | 0.068 0.005 DBMET02499 0.058 0.009 DBMET02500 | DBMET02499 | |
| 0.098 | 0.065 | 0.099 | GABA C receptor rho-1 antagonist | 0.099 0.064 DBMET02499 0.099 0.063 DBMET02500 | DBMET02500 | |
| 0.055 | 0.023 | 0.066 | Glucose-6-phosphate isomerase inhibitor | 0.066 0.014 DBMET02499 0.049 0.031 DBMET02500 | DBMET02499 | |
| 0.081 | 0.049 | 0.097 | Na+ K+ transporting ATPase inhibitor | 0.097 0.034 DBMET02499 0.085 0.045 DBMET02500 | DBMET02499 | |
| 0.071 | 0.039 | 0.078 | Leukotriene antagonist | 0.078 0.033 DBMET02499 0.078 0.033 DBMET02500 | DBMET02500 | |
| 0.054 | 0.023 | 0.056 | Microtubule stabilization | 0.056 0.019 DBMET02499 0.052 0.025 DBMET02500 | DBMET02499 | |
| 0.204 | 0.174 | 0.263 | Apoptosis antagonist | 0.263 0.115 DBMET02499 0.259 0.119 DBMET02500 | DBMET02499 | |
| 0.064 | 0.035 | 0.077 | Beta 2 adrenoreceptor agonist | 0.077 0.011 DBMET02499 0.071 0.018 DBMET02500 | DBMET02499 | |
| 0.091 | 0.064 | 0.095 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.095 0.059 DBMET02499 | DBMET02499 | |
| 0.116 | 0.089 | 0.139 | Bone formation stimulant | 0.13 0.077 DBMET02499 0.139 0.069 DBMET02500 | DBMET02500 | |
| 0.245 | 0.218 | 0.34 | Cyclophilin D inhibitor | 0.34 0.13 DBMET02499 0.272 0.188 DBMET02500 | DBMET02499 | |
| 0.034 | 0.008 | 0.034 | Lysophosphatidic acid receptor 1 agonist | 0.03 0.011 DBMET02499 0.024 0.019 DBMET02500 | ||
| 0.048 | 0.023 | 0.055 | HIV-1 protease inhibitor | 0.055 0.016 DBMET02499 0.047 0.024 DBMET02500 | DBMET02499 | |
| 0.058 | 0.034 | 0.086 | Sphingosine kinase 2 inhibitor | 0.086 0.012 DBMET02499 0.066 0.025 DBMET02500 | DBMET02499 | |
| 0.066 | 0.042 | 0.091 | Neuraminidase (influenza) inhibitor | 0.091 0.019 DBMET02499 0.079 0.026 DBMET02500 | DBMET02499 | |
| 0.064 | 0.042 | 0.067 | Nitric oxide donor | 0.067 0.037 DBMET02499 0.062 0.046 DBMET02500 | DBMET02499 | |
| 0.114 | 0.092 | 0.114 | Sodium channel blocker | |||
| 0.082 | 0.061 | 0.089 | Estrogen-related receptor beta agonist | 0.089 0.043 DBMET02499 0.089 0.044 DBMET02500 | DBMET02500 | |
| 0.046 | 0.025 | 0.046 | Sphingosine 1-phosphate receptor 1 agonist | 0.044 0.027 DBMET02499 | ||
| 0.123 | 0.103 | 0.153 | Acetylcholine M1 receptor antagonist | 0.153 0.072 DBMET02499 | DBMET02499 | |
| 0.072 | 0.053 | 0.099 | Glutamate dehydrogenase inhibitor | 0.099 0.031 DBMET02499 | DBMET02499 | |
| 0.027 | 0.008 | 0.027 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.039 | 0.02 | 0.039 | Phosphoglycerate kinase inhibitor | 0.039 0.02 DBMET02499 0.035 0.024 DBMET02500 | ||
| 0.024 | 0.006 | 0.024 | Antibiotic Anthracycline-like | 0.022 0.008 DBMET02499 0.024 0.006 DBMET02500 | ||
| 0.022 | 0.005 | 0.022 | Lysophosphatidic acid receptor 3 agonist | 0.017 0.007 DBMET02499 0.013 0.01 DBMET02500 | ||
| 0.06 | 0.044 | 0.086 | Neuraminidase inhibitor | 0.086 0.021 DBMET02499 0.075 0.029 DBMET02500 | DBMET02499 | |
| 0.082 | 0.066 | 0.086 | Transcription factor NF kappa B stimulant | 0.086 0.057 DBMET02499 0.08 0.071 DBMET02500 | DBMET02499 | |
| 0.065 | 0.05 | 0.067 | Glutamate (mGluR6) antagonist | 0.067 0.047 DBMET02499 | DBMET02499 | |
| 0.055 | 0.04 | 0.074 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.074 0.023 DBMET02499 | DBMET02499 | |
| 0.03 | 0.016 | 0.032 | Vasopressin 1A agonist | 0.032 0.013 DBMET02499 0.03 0.017 DBMET02500 | DBMET02499 | |
| 0.026 | 0.013 | 0.026 | 5 Hydroxytryptamine 4 agonist | |||
| 0.052 | 0.04 | 0.072 | Acyl-CoA dehydrogenase inhibitor | 0.072 0.025 DBMET02499 | DBMET02499 | |
| 0.068 | 0.057 | 0.084 | Aminopeptidase I inhibitor | 0.084 0.039 DBMET02499 | DBMET02499 | |
| 0.032 | 0.022 | 0.035 | Glutamate (mGluR3) agonist | 0.035 0.016 DBMET02499 0.033 0.021 DBMET02500 | DBMET02499 | |
| 0.117 | 0.106 | 0.143 | Mannose-6-phosphate isomerase inhibitor | 0.143 0.071 DBMET02499 | DBMET02499 | |
| 0.098 | 0.088 | 0.098 | Electron transport complex I inhibitor | 0.097 0.089 DBMET02500 | ||
| 0.043 | 0.033 | 0.043 | Sphingosine 1-phosphate receptor agonist | |||
| 0.035 | 0.026 | 0.035 | Renin inhibitor | 0.031 0.03 DBMET02499 | ||
| 0.023 | 0.015 | 0.029 | Prostaglandin F2 alpha agonist | 0.029 0.009 DBMET02499 0.023 0.014 DBMET02500 | DBMET02499 | |
| 0.13 | 0.122 | 0.137 | Ca2+-transporting ATPase inhibitor | 0.137 0.084 DBMET02499 | DBMET02499 | |
| 0.08 | 0.073 | 0.087 | Interleukin 5 antagonist | 0.078 0.077 DBMET02499 0.087 0.059 DBMET02500 | DBMET02500 | |
| 0.032 | 0.026 | 0.034 | Fumarate hydratase inhibitor | 0.034 0.024 DBMET02499 | DBMET02499 | |
| 0.05 | 0.045 | 0.055 | Leukotriene B4 antagonist | 0.054 0.037 DBMET02499 0.055 0.035 DBMET02500 | DBMET02500 | |
| 0.037 | 0.032 | 0.046 | Toll-Like receptor 2 agonist | 0.046 0.025 DBMET02499 | DBMET02499 | |
| 0.122 | 0.118 | 0.139 | Growth hormone agonist | 0.139 0.097 DBMET02499 0.128 0.11 DBMET02500 | DBMET02499 | |
| 0.087 | 0.083 | 0.118 | GABA C receptor agonist | 0.118 0.051 DBMET02499 | DBMET02499 | |
| 0.029 | 0.026 | 0.029 | Cholesterol ester transfer protein antagonist | |||
| 0.063 | 0.06 | 0.072 | Amidase inhibitor | 0.072 0.046 DBMET02499 | DBMET02499 | |
| 0.097 | 0.095 | 0.114 | Acetylcholine muscarinic antagonist | 0.114 0.074 DBMET02499 | DBMET02499 | |
| 0.133 | 0.132 | 0.21 | Interleukin antagonist | 0.183 0.094 DBMET02499 0.21 0.079 DBMET02500 | DBMET02500 | |
| 0.021 | 0.02 | 0.023 | Isoleucine-tRNA ligase inhibitor | 0.023 0.015 DBMET02499 | DBMET02499 | |
| 0.033 | 0.032 | 0.034 | Antibiotic Aminoglycoside-like | 0.034 0.029 DBMET02499 0.033 0.03 DBMET02500 | DBMET02499 | |
| 0.071 | 0.071 | 0.098 | Carbonic anhydrase VI inhibitor | 0.098 0.04 DBMET02499 0.097 0.041 DBMET02500 | DBMET02499 | |
| 0.091 | 0.093 | 0.098 | Interleukin 1b antagonist | 0.098 0.084 DBMET02500 | DBMET02500 | |
| 0.089 | 0.091 | 0.145 | Cystathionine beta-synthase inhibitor | 0.125 0.054 DBMET02499 0.145 0.043 DBMET02500 | DBMET02500 | |
| 0.047 | 0.05 | 0.059 | Vanilloid 2 antagonist | 0.059 0.025 DBMET02499 0.05 0.041 DBMET02500 | DBMET02499 | |
| 0.026 | 0.03 | 0.028 | Prostaglandin agonist | 0.028 0.025 DBMET02499 | DBMET02499 | |
| 0.049 | 0.054 | 0.066 | Biliverdin reductase inhibitor | 0.066 0.035 DBMET02499 | DBMET02499 | |
| 0.142 | 0.15 | 0.203 | Neurotrophic factor enhancer | 0.203 0.073 DBMET02499 0.18 0.097 DBMET02500 | DBMET02499 | |
| 0.018 | 0.026 | 0.027 | Beta 1 adrenoreceptor agonist | 0.027 0.011 DBMET02499 0.022 0.016 DBMET02500 | DBMET02499 | |
| 0.094 | 0.102 | 0.112 | MAP kinase kinase inhibitor | 0.112 0.082 DBMET02499 | DBMET02499 | |
| 0.184 | 0.197 | 0.257 | Caspase 3 stimulant | 0.257 0.107 DBMET02500 | DBMET02500 | |
| 0.035 | 0.049 | 0.049 | Antimetabolite | 0.049 0.032 DBMET02499 | DBMET02499 | |
| 0.087 | 0.101 | 0.107 | GABA C receptor antagonist | 0.107 0.068 DBMET02499 0.093 0.089 DBMET02500 | DBMET02499 | |
| 0.12 | 0.136 | 0.171 | Nitric oxide antagonist | 0.15 0.095 DBMET02499 0.171 0.081 DBMET02500 | DBMET02500 | |
| 0.079 | 0.095 | 0.119 | Xanthine oxidase inhibitor | 0.108 0.054 DBMET02499 0.119 0.048 DBMET02500 | DBMET02500 | |
| 0.159 | 0.176 | 0.168 | 5 Hydroxytryptamine 3E antagonist | 0.168 0.143 DBMET02499 | DBMET02499 | |
| 0.082 | 0.1 | 0.102 | Carbonic anhydrase XV inhibitor | 0.093 0.077 DBMET02499 0.102 0.065 DBMET02500 | DBMET02500 | |
| 0.076 | 0.095 | 0.101 | Urease inhibitor | 0.098 0.07 DBMET02499 0.101 0.066 DBMET02500 | DBMET02500 | |
| 0.049 | 0.07 | 0.056 | Leukotriene C antagonist | 0.056 0.041 DBMET02499 | DBMET02499 | |
| 0.071 | 0.092 | 0.101 | Aminopeptidase B inhibitor | 0.101 0.064 DBMET02499 | DBMET02499 | |
| 0.038 | 0.061 | 0.061 | Beta tubulin antagonist | 0.061 0.039 DBMET02500 | DBMET02500 | |
| 0.049 | 0.073 | 0.063 | Prostaglandin F2 alpha antagonist | 0.063 0.042 DBMET02499 | DBMET02499 | |
| 0.047 | 0.073 | 0.07 | Sphingosine kinase inhibitor | 0.07 0.025 DBMET02499 | DBMET02499 | |
| 0.08 | 0.107 | 0.104 | AMP-activated protein kinase stimulant | 0.104 0.065 DBMET02499 0.1 0.071 DBMET02500 | DBMET02499 | |
| 0.034 | 0.062 | 0.042 | Neuraminidase (Influenza A) inhibitor | 0.042 0.039 DBMET02499 | DBMET02499 | |
| 0.033 | 0.065 | 0.043 | DNA gyrase subunit A inhibitor | 0.043 0.027 DBMET02500 | DBMET02500 | |
| 0.119 | 0.153 | 0.134 | MAP kinase kinase 4 inhibitor | 0.13 0.114 DBMET02499 0.134 0.103 DBMET02500 | DBMET02500 | |
| 0.069 | 0.103 | 0.106 | Alcohol dehydrogenase inhibitor | 0.106 0.047 DBMET02499 0.092 0.061 DBMET02500 | DBMET02499 | |
| 0.072 | 0.11 | 0.085 | Lanosterol 14 alpha demethylase inhibitor | 0.085 0.082 DBMET02499 | DBMET02499 | |
| 0.111 | 0.15 | 0.19 | Angiogenesis stimulant | 0.178 0.106 DBMET02499 0.19 0.1 DBMET02500 | DBMET02500 | |
| 0.037 | 0.077 | 0.048 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.048 0.047 DBMET02499 | DBMET02499 | |
| 0.069 | 0.112 | 0.082 | D-Ala-D-Ala ligase inhibitor | 0.082 0.063 DBMET02499 0.079 0.073 DBMET02500 | DBMET02499 | |
| 0.11 | 0.155 | 0.131 | Sphingosine 1-phosphate receptor 5 antagonist | 0.131 0.098 DBMET02499 | DBMET02499 | |
| 0.077 | 0.123 | 0.091 | Phosphodiesterase 6D inhibitor | 0.091 0.073 DBMET02499 | DBMET02499 | |
| 0.046 | 0.094 | 0.071 | Carbonic anhydrase XIII inhibitor | 0.071 0.057 DBMET02500 | DBMET02500 | |
| 0.064 | 0.115 | 0.076 | MAP kinase kinase 7 inhibitor | 0.076 0.06 DBMET02499 0.074 0.066 DBMET02500 | DBMET02499 | |
| 0.07 | 0.124 | 0.09 | Anabolic | 0.09 0.079 DBMET02499 | DBMET02499 | |
| 0.034 | 0.089 | 0.06 | Selectin antagonist | 0.06 0.049 DBMET02499 | DBMET02499 | |
| 0.165 | 0.22 | 0.208 | Insulysin inhibitor | 0.208 0.145 DBMET02499 | DBMET02499 | |
| 0.056 | 0.115 | 0.083 | MAO A inhibitor | 0.083 0.078 DBMET02500 | DBMET02500 | |
| 0.077 | 0.14 | 0.113 | DOPA decarboxylase inhibitor | 0.113 0.054 DBMET02499 0.107 0.064 DBMET02500 | DBMET02499 | |
| 0.06 | 0.127 | 0.09 | Prolactin inhibitor | 0.09 0.066 DBMET02499 | DBMET02499 | |
| 0.109 | 0.178 | 0.138 | CF transmembrane conductance regulator agonist | 0.138 0.1 DBMET02500 | DBMET02500 | |
| 0.06 | 0.13 | 0.081 | Breast cancer-resistant protein inhibitor | 0.081 0.078 DBMET02500 | DBMET02500 | |
| 0.065 | 0.137 | 0.082 | Vanilloid agonist | 0.082 0.065 DBMET02499 | DBMET02499 | |
| 0.059 | 0.134 | 0.14 | Creatine kinase inhibitor | 0.14 0.028 DBMET02499 0.099 0.06 DBMET02500 | DBMET02499 | |
| 0.167 | 0.254 | 0.211 | Interleukin 2 agonist | 0.211 0.171 DBMET02499 | DBMET02499 | |
| 0.018 | 0.108 | 0.041 | Dopamine D5 agonist | 0.041 0.026 DBMET02499 | DBMET02499 | |
| 0.045 | 0.14 | 0.071 | Macrophage migration inhibitory factor inhibitor | 0.071 0.065 DBMET02500 | DBMET02500 | |
| 0.059 | 0.155 | 0.126 | Chelator | 0.126 0.048 DBMET02499 0.105 0.071 DBMET02500 | DBMET02499 | |
| 0.052 | 0.152 | 0.082 | HIV-1 integrase (Overall Integration) inhibitor | 0.082 0.075 DBMET02499 | DBMET02499 | |
| 0.037 | 0.158 | 0.052 | Adenine nucleotide translocase inhibitor | 0.052 0.05 DBMET02499 | DBMET02499 | |
| 0.055 | 0.187 | 0.106 | Adenylate cyclase inhibitor | 0.106 0.079 DBMET02499 | DBMET02499 | |
| 0.028 | 0.24 | 0.144 | M18 aspartyl aminopeptidase inhibitor | 0.144 0.055 DBMET02499 | DBMET02499 | |
| 0.045 | 0.256 | 0.122 | Lipid peroxidase inhibitor | 0.122 0.092 DBMET02499 0.118 0.096 DBMET02500 | DBMET02499 | |
| 0.04 | 0.358 | 0.117 | Estrogen antagonist | 0.117 0.061 DBMET02500 | DBMET02500 | |
| 0.02 | 0.459 | 0.098 | Estrogen receptor beta antagonist | 0.098 0.068 DBMET02500 | DBMET02500 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |